Please Enable JavaScript

www.cablinginstall.comis using a security service for protection against online attacks.
The service requires full JavaScript support in order to view this website.

Please enable JavaScript on your browser and try again.

www.cablinginstall.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Odyssey Group Intl Inc (OP: ODYY )

0.0380 -0.0013 (-3.31%)

Streaming Delayed Price Updated: 2:40 PM EDT, Aug 21, 2024 Add to My Watchlist

Price and Volume

Volume	117,240
Open	0.0424
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0393
Today's Range	0.0320 - 0.0454
52wk Range	0.0210 - 0.2350
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc.

January 02, 2024

Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.

December 12, 2023

Performance

YTD	-65.45%	-65.45%
1 Month	-31.28%	-31.28%
3 Month	+15.15%	+15.15%
6 Month	-40.62%	-40.62%
1 Year	-66.96%	-66.96%

More News

Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion

November 16, 2023

Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders

November 15, 2023

Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc.

October 18, 2023

Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate

October 05, 2023

From Oragenics, Inc.

Via Business Wire

Odyssey Health Inc. Begins Trading on the OTCQB

October 04, 2023

Odyssey Health, Inc. Presents Concussion Treatment Data at the Military Health System Research Symposium - MHSRS

August 23, 2023

Odyssey Health, Inc. Presents Data at the Special Operations Medical Association - Scientific Assembly

June 08, 2023

Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment

March 30, 2023

Via TheNewswire.com

Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment

March 30, 2023

Via News Direct

Odyssey Health, Inc. Forms Community-Based Partnership with David R. Metcalf Foundation for Military Concussion Research

February 07, 2023

Via News Direct

Odyssey Health, Inc. (ODYY) To Give Corporate Update at Scheduled Annual Meeting of Stockholders in January 2023

December 01, 2022

Via Investor Brand Network

BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Reports on Concussion Drug Progress, Provides Corporate Update

November 23, 2022

Via Investor Brand Network

World Cup 2022 to Feature New Protocol to Respond to Suspected Concussions

November 22, 2022

Via Investor Brand Network

Odyssey Health, Inc. (ODYY) Expands Executive Team of New Subsidiary in Strategic Move to Strengthen Marketing of Concussion, Neurological Therapies

November 21, 2022

Via Investor Brand Network

Surgical Team in Spain Completes First-Ever Intestinal Transplant

November 17, 2022

Via Investor Brand Network

BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Announces Upcoming Annual Meeting of Stockholders

November 15, 2022

Via Investor Brand Network

Odyssey Health, Inc. (ODYY) Focuses on Medical Devices Market with US Patent Application on Breath-Propelled Intranasal Delivery Device

November 14, 2022

Via Investor Brand Network

Study Finds Iron Causes Chronic Heart Failure in Heart Attack Survivors

November 09, 2022

Via Investor Brand Network

New Pharmaceutical Subsidiary Geared to Aid Odyssey Health, Inc. (ODYY) Development of Novel Solutions for Brain Related Medical Treatments

November 07, 2022

Via Investor Brand Network

Experts Concerned That Concussion Protocols Don’t Factor in Women

November 04, 2022

Via Investor Brand Network

BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Announces Expansion of Executive Team

November 03, 2022

Via Investor Brand Network

BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Files for Patent Protection on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device

November 01, 2022

Via Investor Brand Network

BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Pleased with Safety Profile of Its PRV-002 Concussion Treatment

October 31, 2022

Via Investor Brand Network

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.